[ad_1]
The Astrazeneca vaccine may be almost completely ineffective in protecting people with more than 65 years of the Coronavirus. The news comes from the German newspaper Handelsblatt who believes he has confirmed information from government sources: Germany does not expect an efficacy beyond8 percent between over 65. Therefore, the drug Astrazeneca could prove unsuitable for a large segment of the population, a sensational discovery that, if confirmed, will lead governments of all countries to rethink their vaccination campaign in line with this huge limit.
Today’s call from the European Union against the pharmaceutical company to respect the commitments made regarding the delivery times of the doses: “The new AstraZeneca calendar is not acceptable, the EU Commission has written to the company but the answers are not are satisfactory. ” Health Commissioner Stella Kyriakides said. “We want to know how many doses were produced, where and to whom they were delivered,” he concluded. The EU is ready to take any action to protect citizens ”. But at this point, the discovery of the last hours could trigger another major setback.
When the news began to circulate, a spokesman for the company spoke of “absolutely incorrect” information. “In the United Kingdom it was administered to this segment of the population (over 65 years) without dose adjustments in the authorization for emergency supply – Pfizer argues -. And in November we published data on The lancet which shows that the elderly have shown a strong immune response to our vaccine.
Read also:
[ad_2]
